首页> 外文OA文献 >Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito
【2h】

Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito

机译:内镜黏膜下剥离术后消化道症状和功能的特点及使用rikkunshito治疗胃肠道症状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to investigate the gastrointestinal (GI) symptoms and gastric emptying following endoscopic submucosal dissection (ESD), as well as to evaluate a novel treatment strategy using rikkunshito, a traditional Japanese herbal medicine. GI symptoms and gastric emptying were evaluated 6-8 days after ESD as part of the Step I study. In the Step 1 study, the Gastrointestinal Symptom Rating Scale (GSRS) scores of the two groups after 4 and 8 weeks of treatment with either a proton pump inhibitor (PPI; PPI monotreatment group, n=5) or a PPI plus rikkunshito (PPI + rikkunshito group, n=8) were compared against baseline values. Abdominal pain and constipation occurred in the majority of patients after ESD. The mean T-max 6-8 days after gastric emptying was 75.4±13.6 min, which was significantly longer compared with that reported in healthy subjects (43.9±10.3 min). In the Step 2 study, the total GSRS score was significantly improved only in the PPI + rikkunshito group after 8 weeks of treatment. In conclusion, ESD affects gastric emptying and is associated with an increased incidence of upper GI symptoms such as abdominal pain and indigestion. Rikkunshito may be useful as a novel supporting therapeutic drug for the treatment of GI symptoms in patients who have undergone ESD.
机译:本研究的目的是研究内镜下粘膜下剥离术(ESD)后的胃肠道(GI)症状和胃排空,以及评估使用传统日本草药rikkunshito的新型治疗策略。 ESD后6-8天评估GI症状和胃排空,这是我研究的一部分。在第1步研究中,质子泵抑制剂(PPI; PPI单药治疗组,n = 5)或PPI加rikkunshito(PPI)治疗4周和8周后,两组的胃肠道症状评定量表(GSRS)得分+ rikkunshito组,n = 8)与基线值进行比较。 ESD后大多数患者发生腹部疼痛和便秘。胃排空后6-8天的平均T-max为75.4±13.6 min,与健康受试者的报告值(43.9±10.3 min)相比明显更长。在第2步研究中,治疗8周后,仅PPI + rikkunshito组的总GSRS得分显着提高。总之,ESD影响胃排空,并与上消化道症状(如腹痛和消化不良)的发生率增加相关。 Rikkunshito可用作新型辅助治疗药物,可用于治疗ESD患者的GI症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号